{"count": 16, "results": [{"_id": "34764663", "pmid": 34764663, "pmcid": "PMC8577516", "title": "Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes", "journal": "Diabetes Metab Syndr Obes", "authors": ["Song L", "Kong X", "Yang Z", "Zhang J", "Yang W", "Zhang B", "Chen X", "Wang X"], "date": "2021-11-05T00:00:00Z", "doi": "10.2147/DMSO.S325683", "meta_date_publication": "2021", "meta_volume": "14", "meta_issue": "", "meta_pages": "4451-4458", "score": 50275.188, "text_hl": "@CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@Acarbose@@@ Reduces Low-Grade @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@Albuminuria@@@ Compared to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in Chinese @SPECIES_9606 @@@Patients@@@ with Newly Diagnosed @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@", "citations": {"NLM": "Song L, Kong X, Yang Z, Zhang J, Yang W, Zhang B, Chen X, Wang X. Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes Diabetes Metab Syndr Obes. 2021;14():4451-4458. PMID: 34764663", "BibTeX": "@article{34764663, title={Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes}, author={Song L and Kong X and Yang Z and Zhang J and Yang W and Zhang B and Chen X and Wang X}, journal={Diabetes Metab Syndr Obes}, volume={14}, pages={4451-4458}}"}}, {"_id": "34134654", "pmid": 34134654, "pmcid": "PMC8207700", "title": "Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study", "journal": "BMC Nephrol", "authors": ["Farah RI", "Al-Sabbagh MQ", "Momani MS", "Albtoosh A", "Arabiat M", "Abdulraheem AM", "Aljabiri H", "Abufaraj M"], "date": "2021-06-16T00:00:00Z", "doi": "10.1186/s12882-021-02429-4", "meta_date_publication": "2021 Jun 16", "meta_volume": "22", "meta_issue": "1", "meta_pages": "223", "score": 50260.703, "text_hl": "The use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and RAAS blocker was negatively associated with the presence of @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@albuminuria@@@ (beta coefficient: - 0.6 and -0.33, respectively; p < 0.01). ", "citations": {"NLM": "Farah RI, Al-Sabbagh MQ, Momani MS, Albtoosh A, Arabiat M, Abdulraheem AM, Aljabiri H, Abufaraj M. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study BMC Nephrol. 2021 Jun 16;22(1):223. PMID: 34134654", "BibTeX": "@article{34134654, title={Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study}, author={Farah RI and Al-Sabbagh MQ and Momani MS and Albtoosh A and Arabiat M and Abdulraheem AM and Aljabiri H and Abufaraj M}, journal={BMC Nephrol}, volume={22}, number={1}, pages={223}}"}}, {"_id": "31958303", "pmid": 31958303, "pmcid": "PMC7039575", "title": "Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naive patients with type 2 diabetes: initial triple study", "journal": "BMJ Open Diabetes Res Care", "authors": ["Lim S", "Ku EJ", "Lee SY", "Lee JH", "Lee JE", "Kim KM", "Davies MJ"], "date": "2020-01-01T00:00:00Z", "doi": "10.1136/bmjdrc-2019-000807", "meta_date_publication": "2020 Jan", "meta_volume": "8", "meta_issue": "1", "meta_pages": "", "score": 50258.8, "text_hl": "In the conventional group, if the HbA1c level was >8.0% at 2 and 5 months, the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose was increased by 25%-50% or the @CHEMICAL_glimepiride @CHEMICAL_MESH:C057619 @@@glimepiride@@@ dose was increased by 25%-50% if the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ dose exceeded 2000 mg/day. ", "citations": {"NLM": "Lim S, Ku EJ, Lee SY, Lee JH, Lee JE, Kim KM, Davies MJ. Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naive patients with type 2 diabetes: initial triple study BMJ Open Diabetes Res Care. 2020 Jan;8(1):. PMID: 31958303", "BibTeX": "@article{31958303, title={Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naive patients with type 2 diabetes: initial triple study}, author={Lim S and Ku EJ and Lee SY and Lee JH and Lee JE and Kim KM and Davies MJ}, journal={BMJ Open Diabetes Res Care}, volume={8}, number={1}}"}}, {"_id": "32249610", "pmid": 32249610, "title": "Metformin arrests the progression of established kidney disease in the subtotal nephrectomy model of chronic kidney disease.", "journal": "Am J Physiol Renal Physiol", "authors": ["Borges CM", "Fujihara CK", "Malheiros DMAC", "de Ávila VF", "Formigari GP", "Lopes de Faria JB"], "date": "2020-05-01T00:00:00Z", "doi": "10.1152/ajprenal.00539.2019", "meta_date_publication": "2020 May 1", "meta_volume": "318", "meta_issue": "5", "meta_pages": "F1229-F1236", "score": 50253.613, "text_hl": "However, after 120 days, Nx @SPECIES_10116 @@@rats@@@ that had been treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ displayed significant reductions in @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@albuminuria@@@ levels and in markers of @DISEASE_Fibrosis @DISEASE_MESH:D005355 @@@renal fibrosis@@@. ", "citations": {"NLM": "Borges CM, Fujihara CK, Malheiros DMAC, de Ávila VF, Formigari GP, Lopes de Faria JB. Metformin arrests the progression of established kidney disease in the subtotal nephrectomy model of chronic kidney disease. Am J Physiol Renal Physiol. 2020 May 1;318(5):F1229-F1236. PMID: 32249610", "BibTeX": "@article{32249610, title={Metformin arrests the progression of established kidney disease in the subtotal nephrectomy model of chronic kidney disease.}, author={Borges CM and Fujihara CK and Malheiros DMAC and de Ávila VF and Formigari GP and Lopes de Faria JB}, journal={Am J Physiol Renal Physiol}, volume={318}, number={5}, pages={F1229-F1236}}"}}, {"_id": "30531690", "pmid": 30531690, "pmcid": "PMC6300415", "title": "Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria", "journal": "Med Sci Monit", "authors": ["Pan Q", "Xu Y", "Yang N", "Gao X", "Liu J", "Yang W", "Wang G"], "date": "2018-12-10T00:00:00Z", "doi": "10.12659/MSM.911979", "meta_date_publication": "2018 Dec 10", "meta_volume": "24", "meta_issue": "", "meta_pages": "8941-8949", "score": 50086.22, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ or @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@Acarbose@@@ Treatment Significantly Reduced @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@Albuminuria@@@ in @SPECIES_9606 @@@Patients@@@ with Newly Diagnosed @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@Type 2 Diabetes Mellitus@@@ and Low-Grade @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@Albuminuria@@@", "citations": {"NLM": "Pan Q, Xu Y, Yang N, Gao X, Liu J, Yang W, Wang G. Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria Med Sci Monit. 2018 Dec 10;24():8941-8949. PMID: 30531690", "BibTeX": "@article{30531690, title={Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria}, author={Pan Q and Xu Y and Yang N and Gao X and Liu J and Yang W and Wang G}, journal={Med Sci Monit}, volume={24}, pages={8941-8949}}"}}, {"_id": "28393693", "pmid": 28393693, "title": "Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.", "journal": "Curr Med Chem", "authors": ["Eisenreich A", "Leppert U"], "date": "2017-01-01T00:00:00Z", "doi": "10.2174/0929867324666170404143102", "meta_date_publication": "2017", "meta_volume": "24", "meta_issue": "31", "meta_pages": "3397-3412", "score": 50054.145, "text_hl": "Update on the Protective Renal Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @DISEASE_Diabetic_Nephropathies @DISEASE_MESH:D003928 @@@Diabetic Nephropathy@@@.", "citations": {"NLM": "Eisenreich A, Leppert U. Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy. Curr Med Chem. 2017;24(31):3397-3412. PMID: 28393693", "BibTeX": "@article{28393693, title={Update on the Protective Renal Effects of Metformin in Diabetic Nephropathy.}, author={Eisenreich A and Leppert U}, journal={Curr Med Chem}, volume={24}, number={31}, pages={3397-3412}}"}}, {"_id": "24241085", "pmid": 24241085, "title": "Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.", "journal": "Iran J Kidney Dis", "authors": ["Nasri H", "Baradaran A", "Ardalan MR", "Mardani S", "Momeni A", "Rafieian-Kopaei M"], "date": "2013-11-01T00:00:00Z", "meta_date_publication": "2013 Nov", "meta_volume": "7", "meta_issue": "6", "meta_pages": "423-8", "score": 50053.652, "text_hl": "Moreover, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ significantly decreases @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@albuminuria@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@. ", "citations": {"NLM": "Nasri H, Baradaran A, Ardalan MR, Mardani S, Momeni A, Rafieian-Kopaei M. Bright renoprotective properties of metformin: beyond blood glucose regulatory effects. Iran J Kidney Dis. 2013 Nov;7(6):423-8. PMID: 24241085", "BibTeX": "@article{24241085, title={Bright renoprotective properties of metformin: beyond blood glucose regulatory effects.}, author={Nasri H and Baradaran A and Ardalan MR and Mardani S and Momeni A and Rafieian-Kopaei M}, journal={Iran J Kidney Dis}, volume={7}, number={6}, pages={423-8}}"}}, {"_id": "27320183", "pmid": 27320183, "title": "Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study.", "journal": "J Diabetes Complications", "authors": ["Goldshtein I", "Karasik A", "Melzer-Cohen C", "Engel SS", "Yu S", "Sharon O", "Brodovicz K", "Gadir N", "Katzeff HL", "Radican L", "Chodick G", "Shalev V", "Tunceli K"], "date": "2016-09-01T00:00:00Z", "doi": "10.1016/j.jdiacomp.2016.05.012", "meta_date_publication": "2016 Sep-Oct", "meta_volume": "30", "meta_issue": "7", "meta_pages": "1354-9", "score": 50052.367, "text_hl": "Urinary albumin excretion with @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@ compared to @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylurea@@@ as add on to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@albuminuria@@@: A real-world evidence study.", "citations": {"NLM": "Goldshtein I, Karasik A, Melzer-Cohen C, Engel SS, Yu S, Sharon O, Brodovicz K, Gadir N, Katzeff HL, Radican L, Chodick G, Shalev V, Tunceli K. Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study. J Diabetes Complications. 2016 Sep-Oct;30(7):1354-9. PMID: 27320183", "BibTeX": "@article{27320183, title={Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study.}, author={Goldshtein I and Karasik A and Melzer-Cohen C and Engel SS and Yu S and Sharon O and Brodovicz K and Gadir N and Katzeff HL and Radican L and Chodick G and Shalev V and Tunceli K}, journal={J Diabetes Complications}, volume={30}, number={7}, pages={1354-9}}"}}, {"_id": "26733332", "pmid": 26733332, "title": "Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.", "journal": "J Nephrol", "authors": ["Langer S", "Kreutz R", "Eisenreich A"], "date": "2016-12-01T00:00:00Z", "doi": "10.1007/s40620-015-0258-1", "meta_date_publication": "2016 Dec", "meta_volume": "29", "meta_issue": "6", "meta_pages": "765-773", "score": 50050.49, "text_hl": "High-@CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@glucose@@@ modulates @GENE_PRKAB1 @GENE_5564 @@@AMP-activated protein kinase@@@ (@GENE_PRKAB1 @GENE_5564 @@@AMPK@@@) signaling and cell apoptosis. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has been demonstrated to reduce apoptosis and @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@albuminuria@@@ in @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@. ", "citations": {"NLM": "Langer S, Kreutz R, Eisenreich A. Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions. J Nephrol. 2016 Dec;29(6):765-773. PMID: 26733332", "BibTeX": "@article{26733332, title={Metformin modulates apoptosis and cell signaling of human podocytes under high glucose conditions.}, author={Langer S and Kreutz R and Eisenreich A}, journal={J Nephrol}, volume={29}, number={6}, pages={765-773}}"}}, {"_id": "16034881", "pmid": 16034881, "title": "Metformin monotherapy for type 2 diabetes mellitus.", "journal": "Cochrane Database Syst Rev", "authors": ["Saenz A", "Fernandez-Esteban I", "Mataix A", "Ausejo M", "Roque M", "Moher D"], "date": "2005-07-20T00:00:00Z", "doi": "10.1002/14651858.CD002966.pub3", "meta_date_publication": "2005 Jul 20", "meta_volume": "", "meta_issue": "3", "meta_pages": "CD002966", "score": 50049.35, "text_hl": "OBJECTIVES: To assess the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy on mortality, morbidity, quality of life, glycaemic control, body weight, @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@ levels, blood pressure, insulinaemia, and @<m>DISEASE_Albuminuria</m> @DISEASE_MESH:D000419 @@@albuminuria@@@ in @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@. ", "citations": {"NLM": "Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D. Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD002966. PMID: 16034881", "BibTeX": "@article{16034881, title={Metformin monotherapy for type 2 diabetes mellitus.}, author={Saenz A and Fernandez-Esteban I and Mataix A and Ausejo M and Roque M and Moher D}, journal={Cochrane Database Syst Rev}, number={3}, pages={CD002966}}"}}]}